Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Zidovudine intolerance.

Groopman JE.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S500-6. Review.

PMID:
2201071
2.
3.
4.

Hematologic toxicity of zidovudine in HIV-infected patients.

Brogan KL, Zell SC.

Am Fam Physician. 1990 May;41(5):1521-8.

PMID:
1692180
7.
9.

A cost analysis of approved antiretroviral strategies in persons with advanced human immunodeficiency virus disease and zidovudine intolerance.

Bozzette SA, Parker R, Hay J.

J Acquir Immune Defic Syndr. 1994 Apr;7(4):355-62. Erratum in: J Acquir Immune Defic Syndr 1994 Nov;7(11):1212.

PMID:
7510808
11.

Management of the hematologic complications of human immunodeficiency virus infection.

Groopman JE.

Rev Infect Dis. 1990 Sep-Oct;12(5):931-7. Review.

PMID:
2237134
12.

Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.

Chen SC, Barker SM, Mitchell DH, Stevens SM, O'Neill P, Cunningham AL.

Pathology. 1992 Apr;24(2):109-11.

PMID:
1641255
13.

The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.

Miles SA, Golde DW, Mitsuyasu RT.

Hematol Oncol Clin North Am. 1991 Apr;5(2):267-80. Review.

PMID:
2022593
15.

Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.

Pinching AJ, Helbert M, Peddle B, Robinson D, Janes K, Gor D, Jeffries DJ, Stoneham C, Mitchell D, Kocsis AE, et al.

J Infect. 1989 Jan;18 Suppl 1:33-40.

PMID:
2521663
16.

Hematopoietic growth factors as adjuncts to antiretroviral therapy.

Miles SA.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1073-80. Review.

PMID:
1380256
17.

[The treatment of 12 HIV-infected children with zidovudine].

Scherpbier HJ, Prakken AB, de Graeff-Meeder ER, van den Berg H.

Ned Tijdschr Geneeskd. 1993 Aug 7;137(32):1610-3. Dutch.

PMID:
8366963
19.

Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.

Hewitt RG, Morse GD, Lawrence WD, Maliszewski ML, Santora J, Bartos L, Bonnem E, Poiesz B.

Antimicrob Agents Chemother. 1993 Mar;37(3):512-22.

20.

Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection.

Luster MI, Rosenthal GJ, Cao W, Thompson MB, Munson AE, Prejean JD, Shopp G, Fuchs BA, Germolec DR, Tomaszewski JE.

Int J Immunopharmacol. 1991;13 Suppl 1:99-107.

PMID:
1668555
Items per page

Supplemental Content

Write to the Help Desk